3d9c454b22084467bba629731d8d4a5143851709613a4d8eb7c70d440af58a4847f98a646a19453eb85e1e13bdeba16681e8b9217d664181bb51446dcd7d65929d718429d4b94cbb866755e3221636a2a5974ef0faec4f95a675b0ffec7cec9fa9cea80848c9452c9ace5e90d497750bbc091e9e0d214fb8bf1cd3fe1e120396bd52c6705f584498997c7b6667d03cfcc76686d3a2c243989d1201e836814f9b
agent
In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii IsolatesExtensive genetic diversity within the Dutch clinical Cryptococcus neoformans population.Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in CubaReactivation of a Cryptococcus gattii infection in a cheetah (Acinonyx jubatus) held in the National Zoo, Havana, CubaIn Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitisMicrosatellite Typing of Clinical and Environmental Cryptococcus neoformans var. grubii Isolates from Cuba Shows Multiple Genetic LineagesCryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal speciesKodamaea (Pichia) ohmeri fungemia in a pediatric patient admitted in a public hospitalIn Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp
author
type
label
M.T. Illnait-Zaragozi
firstName
lastName
Illnait-Zaragozi